Nanobiotix S.A. (EPA:NANO)

Nanobiotix Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	110.89	52.75	49.74	75.28	41.39	83.92
Cash & Short-Term Investments	110.89	52.75	49.74	75.28	41.39	83.92
Cash Growth	284.80%	6.06%	-33.93%	81.90%	-50.68%	-29.57%
Accounts Receivable	1.93	2.14	2.98	2.97	0.1	-
Other Receivables	7.44	5.55	5.56	5.43	5.19	3.93
Receivables	9.37	7.68	8.54	8.4	5.29	3.93
Prepaid Expenses	3.22	2.32	3.2	2.56	2.98	2.21
Other Current Assets	-0	0	-0	1.1	2.7	3
Total Current Assets	123.48	62.75	61.47	87.34	52.36	93.06
Property, Plant & Equipment	4	4.17	5.29	6.11	7.12	8.19
Other Intangible Assets	0.01	0.01	0.01	0.01	0	0
Other Long-Term Assets	0.41	0.83	0.66	0.44	0.29	0.52
Total Assets	128.33	67.76	67.42	93.9	59.77	101.77

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	6.16	6.58	4.48	6.7	4	5
Accrued Expenses	7.45	9.14	21.89	18.3	11.63	6.31
Current Portion of Long-Term Debt	30.83	3.1	3.66	3.82	3.6	7.08
Current Portion of Leases	1.23	1.21	1.26	1.2	0.96	1.13
Current Income Taxes Payable	0.55	0.22	0.54	0.45	0.36	0.26
Current Unearned Revenue	36.17	36.22	18.16	18.23	16.57	16.77
Other Current Liabilities	3.54	1.04	8.94	1.18	0.82	0.31
Total Current Liabilities	85.93	57.51	58.94	49.87	37.94	36.85
Long-Term Debt	73.28	89.12	43.01	41.66	44.04	32.42
Long-Term Leases	1.27	1.89	2.97	3.88	4.57	5.39
Pension & Post-Retirement Benefits	0.56	0.51	0.43	0.32	0.27	0.32
Other Long-Term Liabilities	0.68	3.22	27.78	0	-	-
Total Liabilities	161.71	152.24	133.12	95.74	86.81	74.98

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	1.53	1.45	1.42	1.41	1.05	1.05
Additional Paid-In Capital	396.87	314.4	312.74	312.74	255.76	255.77
Retained Earnings	-34.29	-23.96	-68.13	-39.7	-57.04	-47
Treasury Stock	-0.23	-0.23	-0.23	-0.23	-0.23	-0.2
Comprehensive Income & Other	-397.26	-376.15	-311.51	-276.07	-226.58	-182.82
Shareholders' Equity	-33.38	-84.48	-65.7	-1.84	-27.05	26.79
Total Liabilities & Equity	128.33	67.76	67.42	93.9	59.77	101.77

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	106.61	95.32	50.9	50.57	53.17	46.02
Net Cash (Debt)	4.28	-42.57	-1.17	24.72	-11.78	37.9
Net Cash Growth	-	-	-	-	-	-45.99%
Net Cash Per Share	0.09	-0.89	-0.02	0.67	-0.34	1.09
Filing Date Shares Outstanding	50.8	48.39	47.4	47.11	34.85	34.81
Total Common Shares Outstanding	50.8	48.39	47.4	47.11	34.85	34.81
Working Capital	37.55	5.24	2.53	37.47	14.42	56.22
Book Value Per Share	-0.66	-1.75	-1.39	-0.04	-0.78	0.77
Tangible Book Value	-33.39	-84.49	-65.71	-1.85	-27.05	26.79
Tangible Book Value Per Share	-0.66	-1.75	-1.39	-0.04	-0.78	0.77
Machinery	7.38	7.3	7.14	6.73	6.49	6.5
Construction In Progress	0.78	0.25	0.14	0.04	0.34	0.1

Data Source: S&P Global Market Intelligence Last updated: Sep 24, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 2, 2026

Data Sources Report a data error